Peter A. Hosick
Montclair State University
47 Papers
208 Citations
Peter A. Hosick is an academic researcher from Montclair State University. The author has contributed to research in topics: Medicine & Bilirubin. The author has an hindex of 16, co-authored 39 publications. Previous affiliations of Peter A. Hosick include Appalachian State University & University of Mississippi Medical Center.
Chat about Author
Papers
Biliverdin Reductase Isozymes in Metabolism
TL;DR: The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions and their roles in metabolism and their potential as therapeutic targets are discussed.
Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.
Terry D. Hinds,Katherine A. Burns,Katherine A. Burns,Peter A. Hosick,Peter A. Hosick,Lucien McBeth,Andrea L. Nestor-Kalinoski,Heather A. Drummond,Abdulhadi A. AlAmodi,Michael W. Hankins,John P. Vanden Heuvel,David E. Stec +11 more
TL;DR: It is reported here that liver BVRA protects against hepatic steatosis by inhibiting glycogen synthase kinase 3β (GSK3β) by enhancing serine 9 phosphorylation, which inhibits its activity.
118
Lipopolysaccharide inhibition of glucose production through the Toll‐like receptor‐4, myeloid differentiation factor 88, and nuclear factor κb pathway
Carl F. Raetzsch,Natasha L. Brooks,J. Mc Kee Alderman,Kelli S. Moore,Peter A. Hosick,Simon Klebanov,Shizuo Akira,James E. Bear,Albert S. Baldwin,Nigel Mackman,Terry P. Combs +10 more
TL;DR: Results suggest that LPS and insulin inhibit glucose production by separate pathways, and recovery from LPS‐induced hypoglycemia was linked to glucose intolerance and hyperinsulinemia in TLR4+/+ mice, but not inTLR4−/− mice.
81
Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα
Terry D. Hinds,Peter A. Hosick,Shujuan Chen,Robert H. Tukey,Michael W. Hankins,Andrea L. Nestor-Kalinoski,David E. Stec +6 more
TL;DR: A chronic but mild endogenous increase in unconjugated hyperbiliubinemia protects against hepatic steatosis through a reduction in Ser(P)73 PPARα, causing an increase in PPAR α transcriptional activity.
76
Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet
Peter A. Hosick,Abdulhadi A. AlAmodi,Megan V. Storm,Monette Gousset,Brandon E. Pruett,Will Gray,Jacob Stout,David E. Stec +7 more
TL;DR: It is demonstrated that chronic CO treatment prevents the development of high-fat diet induced obesity via stimulation of metabolism and remodeling of adipocytes.
60